BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38301409)

  • 1. PARVB promotes malignant melanoma progression and is enhanced by hypoxic conditions.
    Wang T; Wu Z; Bi Y; Wang Y; Zhao C; Sun H; Wu Z; Tan Z; Zhang H; Wei H; Yan W
    Transl Oncol; 2024 Apr; 42():101861. PubMed ID: 38301409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of Novel Methylation-Driven Gene Model and Investigation of PARVB Function in Glioblastoma.
    Yu W; Wu P; Wang F; Miao L; Han B; Jiang Z
    Front Oncol; 2021; 11():705547. PubMed ID: 34568031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.
    Wu CF; Ng KF; Chen CS; Chang PL; Chuang CK; Weng WH; Liao SK; Pang ST
    Br J Cancer; 2010 Sep; 103(6):852-60. PubMed ID: 20736946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer.
    Mongroo PS; Johnstone CN; Naruszewicz I; Leung-Hagesteijn C; Sung RK; Carnio L; Rustgi AK; Hannigan GE
    Oncogene; 2004 Nov; 23(55):8959-70. PubMed ID: 15467740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARVB overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma.
    Eslami A; Miyaguchi K; Mogushi K; Watanabe H; Okada N; Shibuya H; Mizushima H; Miura M; Tanaka H
    Br J Cancer; 2015 Jan; 112(2):338-44. PubMed ID: 25422907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of alphaPIX (ARHGEF6) with beta-parvin (PARVB) suggests an involvement of alphaPIX in integrin-mediated signaling.
    Rosenberger G; Jantke I; Gal A; Kutsche K
    Hum Mol Genet; 2003 Jan; 12(2):155-67. PubMed ID: 12499396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.
    Spinella F; Rosanò L; Del Duca M; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    PLoS One; 2010 Jun; 5(6):e11241. PubMed ID: 20574527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
    Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
    Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells.
    Xue M; Li X; Chen W
    Mol Med Rep; 2015 Aug; 12(2):2121-7. PubMed ID: 25824695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions.
    Mills CN; Joshi SS; Niles RM
    Mol Cancer; 2009 Nov; 8():104. PubMed ID: 19919690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.
    Zhou C; Ye L; Jiang C; Bai J; Chi Y; Zhang H
    Tumour Biol; 2015 Dec; 36(12):9179-88. PubMed ID: 26088446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential hypoxic regulation of hypoxia-inducible factors 1alpha and 2alpha.
    Lin Q; Cong X; Yun Z
    Mol Cancer Res; 2011 Jun; 9(6):757-65. PubMed ID: 21571835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma.
    Fischer AP; Miles SL
    Biomed Pharmacother; 2017 Feb; 86():502-513. PubMed ID: 28012930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer.
    Zhang Q; Lou Y; Zhang J; Fu Q; Wei T; Sun X; Chen Q; Yang J; Bai X; Liang T
    Mol Cancer; 2017 Jul; 16(1):119. PubMed ID: 28705232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells.
    Li Y; Qiu X; Zhang S; Zhang Q; Wang E
    Cancer Biol Ther; 2009 Feb; 8(4):322-30. PubMed ID: 19305150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia.
    Neelam S; Brooks MM; Cammarata PR
    Mol Vis; 2013; 19():1-15. PubMed ID: 23335846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.
    Asnaghi L; Lin MH; Lim KS; Lim KJ; Tripathy A; Wendeborn M; Merbs SL; Handa JT; Sodhi A; Bar EE; Eberhart CG
    PLoS One; 2014; 9(8):e105372. PubMed ID: 25166211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.
    Aquino-Gálvez A; González-Ávila G; Delgado-Tello J; Castillejos-López M; Mendoza-Milla C; Zúñiga J; Checa M; Maldonado-Martínez HA; Trinidad-López A; Cisneros J; Torres-Espíndola LM; Hernández-Jiménez C; Sommer B; Cabello-Gutiérrez C; Gutiérrez-González LH
    Oncol Rep; 2016 Jan; 35(1):577-83. PubMed ID: 26548300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.